Open access
Gastrointestinal bleeding in hepatocellular carcinoma under systemic therapy: Real-world incidence and clinical predictors
L. D. da Fonseca
L. T. Ikeoka
E. Sampaio
Thamires Haick Martins da Silveira
Victor Junji Yamamoto
Marina Acevedo Zarzar de Melo
P. Hoff
J. Sabbaga
Medicine
Abstract
Highlights • GI bleeding occurred in 24.1% of HCC patients during systemic therapy.• GI bleeding reached 23.1% cumulative incidence at 12-months.• Varices, splenomegaly and vascular invasion predicted bleeding risk.• A simple 4-point score stratified GI bleeding risk during treatment.• GI bleeding was associated with 75.5% bleeding-related mortality.